Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.59B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.04B |
| 3 |
Microsoft
MSFT
|
+$794M |
| 4 |
Home Depot
HD
|
+$512M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$357M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$491M |
| 2 |
Linde
LIN
|
+$373M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$298M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$290M |
| 5 |
Salesforce
CRM
|
+$249M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 56.47% |
| 2 | Technology | 8.38% |
| 3 | Healthcare | 7.46% |
| 4 | Consumer Discretionary | 5.14% |
| 5 | Industrials | 5.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4101
Carter Bankshares
CARE
$729M
| $851K | ﹤0.01% |
57,540
+15,256
| +36% | +$216K |
|
|
HAYN
4102
DELISTED
Haynes International, Inc.
HAYN
| $849K | ﹤0.01% |
16,708
-3,687
| -18% | -$175K |
|
4103
Oak Valley Bancorp
OVLY
$286M
| $847K | ﹤0.01% |
33,622
-29,249
| -47% | -$711K |
|
4104
Hydrofarm Holdings
HYFM
$4.04M
| $847K | ﹤0.01% |
108,257
+78,305
| +261% | +$936K |
|
4105
Relmada Therapeutics
RLMD
$462M
| $846K | ﹤0.01% |
343,975
+141,647
| +70% | +$392K |
|
4106
OraSure Technologies
OSUR
$248M
| $845K | ﹤0.01% |
168,692
-966,536
| -85% | -$5.8M |
|
4107
CALL
Vipshop
VIPS
$6.42B
| $845K | ﹤0.01% |
+51,200
| New | +$802K |
|
4108
CALL
Protagonist Therapeutics
PTGX
$9.34B
| $842K | ﹤0.01% |
+30,500
| New | +$763K |
|
|
CCRN
4109
CALL
DELISTED
Cross Country Healthcare
CCRN
| $842K | ﹤0.01% |
+30,000
| New | +$745K |
|
|
AZPN
4110
DELISTED
Aspen Technology Inc
AZPN
| $841K | ﹤0.01% |
5,018
+1,225
| +32% | +$227K |
|
|
4111
PUT
Vipshop
VIPS
$6.42B
| $840K | ﹤0.01% |
+50,900
| New | +$797K |
|
4112
CALL
Transmedics
TMDX
$3.07B
| $840K | ﹤0.01% |
+10,000
| New | +$766K |
|
4113
Workhorse Group
WKHS
$33.6M
| $837K | ﹤0.01% |
320
-68
| -18% | -$196K |
|
4114
CALL
Merit Medical Systems
MMSI
$5.4B
| $836K | ﹤0.01% |
+10,000
| New | +$813K |
|
4115
iShares MSCI Indonesia ETF
EIDO
$491M
| $836K | ﹤0.01% |
36,270
-29,253
| -45% | -$693K |
|
|
BRFS
4116
DELISTED
BRF SA
BRFS
| $829K | ﹤0.01% |
436,213
-3,670,058
| -89% | -$5.66M |
|
4117
CALL
QuidelOrtho
QDEL
$1.01B
| $829K | ﹤0.01% |
+10,000
| New | +$875K |
|
4118
Vornado Realty Trust
VNO
$7.13B
| $827K | ﹤0.01% |
45,600
-99,758
| -69% | -$1.47M |
|
4119
Meridian
MRBK
$230M
| $826K | ﹤0.01% |
84,308
-6,912
| -8% | -$69.9K |
|
|
UDMY
4120
DELISTED
Udemy
UDMY
| $821K | ﹤0.01% |
76,495
-36,360
| -32% | -$347K |
|
4121
PMV Pharmaceuticals
PMVP
$65.2M
| $817K | ﹤0.01% |
130,539
-211,613
| -62% | -$1.11M |
|
4122
Thryv Holdings
THRY
$84.4M
| $817K | ﹤0.01% |
+33,216
| New | +$773K |
|
|
MRSN
4123
CALL
DELISTED
Mersana Therapeutics
MRSN
| $817K | ﹤0.01% |
+9,932
| New | +$1.45M |
|
4124
Adient
ADNT
$1.47B
| $817K | ﹤0.01% |
21,317
-52,871
| -71% | -$1.95M |
|
4125
NACCO Industries
NC
$325M
| $817K | ﹤0.01% |
23,562
-1,403
| -6% | -$48K |
|
Similar funds
Israel Englander's Q2 2023 Portfolio in Review
As of Q2 2023, Israel Englander held 7,181 positions worth $203B, up 16% from $174B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Israel Englander's Q2 2023 filing shows 870 new, 2,213 increased, 2,337 reduced and 1,192 closed positions. Its largest new stake was ResMed: 632,015 shares worth $138M. The largest sale was Tesla, an estimated $491M.
By sector, the portfolio is most concentrated in Miscellaneous at 56% of assets, up from 53% a quarter earlier, followed by Technology and Healthcare.
- Israel Englander's largest Q2 2023 buy was ResMed: 632,015 shares worth $138M.
- Israel Englander added most to iShares Core S&P 500 ETF in Q2 2023, an estimated $1.59B increase.
- Israel Englander's biggest Q2 2023 reduction was Tesla, cutting an estimated $491M.
- Israel Englander fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $237M.
- Israel Englander's ten largest holdings make up 26% of its $203B portfolio in Q2 2023.
- Israel Englander opened 870 new positions and closed 1,192 in Q2 2023.
- Israel Englander's portfolio value rose 16% quarter-over-quarter to $203B.
Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.